Evidence map›Paper›PMID 33273556›Full record

ArticleScientific reports2020

Acute invariant NKT cell activation triggers an immune response that drives prominent changes in iron homeostasis.

Hua Huang, Vanessa Zuzarte-Luis, Gabriela Fragoso, Annie Calvé, Tuan Anh Hoang, Manon Oliero, Geneviève Chabot-Roy, Victor Mullins-Dansereau, Sylvie Lesage, Manuela M Santos

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hua HuangCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Vanessa Zuzarte-LuisInstituto de Medicina Molecular (iMM), Lisbon, Portugal.
Gabriela FragosoCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Annie CalvéCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Tuan Anh HoangCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Manon OlieroCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Geneviève Chabot-RoyMaisonneuve-Rosemont Hospital Research Centre (CRHMR), Montréal, Québec, Canada.
Victor Mullins-DansereauCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Sylvie LesageDépartement de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montréal, Québec, Canada.
Manuela M SantosCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada. manuela.santos@umontreal.ca.
Centre Hospitalier de l’Université de Montréal · CAUniversité de Montréal · CAHôpital Maisonneuve-Rosemont · CAInstituto de Medicina Molecular João Lobo Antunes

Funding

CIHR PJT-159775
6 · The paper itself

Abstract

Iron homeostasis is an essential biological process that ensures the tissue distribution of iron for various cellular processes. As the major producer of hepcidin, the liver is central to the regulation of iron metabolism. The liver is also home to many immune cells, which upon activation may greatly impact iron metabolism. Here, we focus on the role of invariant natural killer T (iNKT) cells, a subset of T lymphocytes that, in mice, is most abundant in the liver. Activation of iNKT cells with the prototypical glycosphingolipid antigen, α-galactosylceramide, resulted in immune cell proliferation and biphasic changes in iron metabolism. This involved an early phase characterized by hypoferremia, hepcidin induction and ferroportin suppression, and a second phase associated with strong suppression of hepcidin despite elevated levels of circulating and tissue iron. We further show that these changes in iron metabolism are fully dependent on iNKT cell activation. Finally, we demonstrate that the biphasic regulation of hepcidin is independent of NK and Kupffer cells, and is initially driven by the STAT3 inflammatory pathway, whereas the second phase is regulated by repression of the BMP/SMAD signaling pathway. These findings indicate that iNKT activation and the resulting cell proliferation influence iron homeostasis.

Indexed as

HomeostasisLymphocyte ActivationAnimalsCation Transport ProteinsCell ProliferationFerroportinGalactosylceramidesHepcidinsIronKiller Cells, NaturalLiverMiceMice, Inbred C57BLCation Transport ProteinsFerroportinGalactosylceramidesHepcidinsIron

Identifiers

PMID33273556
PMCPMC7713400
OpenAlexW3106651890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.